XORTX Therapeutics Inc.
XRTX
$0.45
-$0.02-4.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.83% | -163.83% | -26.83% | 70.31% | -53.53% |
| Total Depreciation and Amortization | -4.27% | -5.46% | -0.38% | 5.71% | -16.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.44% | 64.14% | 55.34% | -83.76% | 83.04% |
| Change in Net Operating Assets | 187.84% | 602.16% | -17.64% | 216.04% | 111.33% |
| Cash from Operations | 24.74% | 27.80% | 30.25% | 44.12% | 44.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -658.35% | 22.37% | -81.94% | -43.84% | 7.60% |
| Cash from Investing | -658.35% | 22.37% | -81.94% | -35.96% | 15.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -28.55% | -41.41% | -56.07% | -16.52% | -5.29% |
| Issuance of Common Stock | -35.87% | 31.53% | -20.01% | -20.01% | 1,172,266.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.56% | -11.40% | 30.29% | 33.00% | -126.18% |
| Cash from Financing | -48.64% | 39.84% | -18.80% | -16.20% | 869.73% |
| Foreign Exchange rate Adjustments | 175.00% | -437.10% | 128.89% | -300.00% | -978.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.22% | 60.02% | 34.70% | 52.36% | 86.06% |